• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal & Metabolism
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality
      • Environment, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Access to Healthcare

Meet Manuel Cobos, transplant surgeon and researcher

Follow Dr. Cobos as he works to provide a patient with a new liver and performs surgery using a tiny video camera.

Jul 31, 2018

Manuel Cobos, a transplant surgeon in Argentina, works with patients suffering from liver failure. For patients who have exhausted other treatment options, transplant surgery may offer the last hope. Unfortunately, liver donors are in short supply, and in a world where liver disease is on the rise, the need for alternative treatments is growing.

To help search for alternatives, in 2015 Dr. Cobos took a three-month break from his normal work to participate in the Next Generation Scientist program run by Novartis and the University of Basel in Switzerland. There he learned about designing and managing clinical trials of experimental treatments in patients. While at Novartis, he met researchers exploring the biological processes that facilitate livers to regenerate themselves. Intrigued, he returned a year later for an internship with the liver research group of Jan Tchorz at the Novartis Institutes for BioMedical Research.

Dr. Cobos is currently working on an M.D.-Ph.D. at the Universidad Nacional de La Plata in Argentina, while also continuing to perform transplants. In 2017, photographer Andrea Bruce followed Dr. Cobos through the process of transplanting a liver.

Transplant surgeon in Argentina confers with colleagues

Dr. Cobos (left) confers with colleagues during his work as a transplant surgeon in Argentina.

Transplant surgeon prepares to operate on liver donor

Here he prepares to operate on a liver donor in Santa Fe, a city in northeastern Argentina.

Transplant team transports donor liver

After the operation, Dr. Cobos and his team head to the airport and board a plane to transport the liver to Buenos Aires, where a patient awaits an organ transplant.

Transplant surgeon finishes preparing donor liver

Back in Buenos Aires and after working all night, Dr. Cobos and his team finish preparing the donated liver for transplantation in one of the hospitals where he works.

Transplant surgeon preps for surgery

Dr. Cobos prepares for the transplant surgery, which was successful.

Transplant team performs laparoscopic surgery using small video camera

He and his team also perform surgery on patients with liver and pancreatic cancers, using a small video camera to guide their work. Called laparoscopic surgery, the approach requires relatively small incisions and typically leads to a quicker recovery than traditional techniques for patients with liver and pancreatic tumors.

Transplant team guides surgical instruments using video monitor

Intent on their work, Dr. Cobos and his team guide their instruments using a video monitor above the operating table. The demand for such emergency treatment is expected to increase with the current epidemic of nonalcoholic fatty liver disease, a condition linked to obesity that can progress to more severe diseases causing liver failure. The global prevalence of fatty liver disease is estimated at 24%, with the highest rates in Latin America.

Transplant surgeon at the end of his day’s work

Dr. Cobos calls it a day.

Shareline

Meet Dr. Manuel Cobos, transplant surgeon in Argentina and alumnus of #NextGenScience program. #AccessInAction
Tweet Tweetpopo

Open resources at Novartis help drive innovation

With help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

Learn more

Tags: 
Access to Healthcare, Next Generation Scientist, Novartis Institutes for BioMedical Research, Working at Novartis, Reimagine Medicine
Disclaimer: 

Photos: Andrea Bruce

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Dr. Theophile Tuyisabe standing next to his patients smiling at him
Access to Healthcare

Meet a visionary who beat the odds to realize his vision of inclusive eye care

Access to Healthcare

Chagas disease: Breaking the silence

Sandoz in Kalwe, India ensures multidrug therapy (MTD) supply to WHO to fight leprosy
Access to Healthcare

Ensuring medicine supply to patients during COVID-19

You are here

  1. Home ›
  2. Stories ›
  3. Access healthcare

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.